Search

everythinglearnresearchcommunity

for

Search:↓

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Blocking interferon-gamma might help treat various autoimmune diseases.

The study found that a key immune pathway protecting hair follicles is reduced in a mouse model of scarring hair loss.

Thymic mesenchymal cells have unique gene expression that supports their specific functions in the thymus.

Immune cells help keep skin healthy and repair it, but imbalance can cause disease.

Thymic epithelial cells may be related to skin stem cells.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

Biodegradable scaffolds help regenerate wounds and hair by activating the immune system.

Myeloid-derived suppressor cells help control autoimmune cells and promote hair regrowth in alopecia areata.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

ILC1-like cells may contribute to hair loss in alopecia areata.

People with Alopecia areata have higher levels of certain T regulatory cells in their blood.

TLR4 is important in aging-related diseases and could be a new treatment target.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Belatacept may be a promising treatment for alopecia areata.

Immune cells are essential for early hair and skin development and healing.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

δ-GABAA receptors affect alcohol consumption based on the estrous cycle and influence movement regardless of the cycle.

Telocytes might help with skin repair and regeneration.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

Certain immune cells in the skin can stop hair from growing.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.